⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recurrent lip and oral cavity squamous cell carcinoma

Every month we try and update this database with for recurrent lip and oral cavity squamous cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaNCT00588770
Neck Squamous C...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Neck ...
Recurrent Oral ...
Recurrent Oroph...
Recurrent Saliv...
Recurrent Sinon...
Salivary Gland ...
Stage IV Hypoph...
Stage IV Major ...
Stage IVA Laryn...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Major...
Stage IVA Oral ...
Stage IVA Oroph...
Stage IVA Sinon...
Stage IVB Laryn...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Major...
Stage IVB Oral ...
Stage IVB Oroph...
Stage IVB Sinon...
Stage IVC Laryn...
Stage IVC Laryn...
Stage IVC Lip a...
Stage IVC Major...
Stage IVC Oral ...
Stage IVC Oroph...
Stage IVC Sinon...
Tongue Carcinom...
Bevacizumab
Carboplatin
Cisplatin
Docetaxel
Fluorouracil
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaNCT00588770
Neck Squamous C...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Neck ...
Recurrent Oral ...
Recurrent Oroph...
Recurrent Saliv...
Recurrent Sinon...
Salivary Gland ...
Stage IV Hypoph...
Stage IV Major ...
Stage IVA Laryn...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Major...
Stage IVA Oral ...
Stage IVA Oroph...
Stage IVA Sinon...
Stage IVB Laryn...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Major...
Stage IVB Oral ...
Stage IVB Oroph...
Stage IVB Sinon...
Stage IVC Laryn...
Stage IVC Laryn...
Stage IVC Lip a...
Stage IVC Major...
Stage IVC Oral ...
Stage IVC Oroph...
Stage IVC Sinon...
Tongue Carcinom...
Bevacizumab
Carboplatin
Cisplatin
Docetaxel
Fluorouracil
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck CancerNCT02068157
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Metas...
Recurrent Oral ...
Recurrent Oroph...
Tongue Carcinom...
Laboratory Biom...
Photodynamic Th...
Porfimer Sodium
18 Years - Roswell Park Cancer Institute
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous TherapyNCT01256385
Recurrent Hypop...
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Metas...
Recurrent Nasal...
Recurrent Nasop...
Recurrent Oral ...
Recurrent Oroph...
Recurrent Saliv...
Salivary Gland ...
Squamous Cell C...
Stage IV Hypoph...
Stage IV Nasoph...
Stage IVA Laryn...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Major...
Stage IVA Nasal...
Stage IVA Oral ...
Stage IVA Oroph...
Stage IVB Laryn...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Major...
Stage IVB Nasal...
Stage IVB Oral ...
Stage IVB Oroph...
Stage IVC Laryn...
Stage IVC Laryn...
Stage IVC Lip a...
Stage IVC Major...
Stage IVC Nasal...
Stage IVC Oral ...
Stage IVC Oroph...
Tongue Carcinom...
Cetuximab
Laboratory Biom...
Temsirolimus
18 Years - National Cancer Institute (NCI)
Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck CancersNCT05063552
Clinical Stage ...
Metastatic Head...
Metastatic Hypo...
Metastatic Lary...
Metastatic Lip ...
Metastatic Nasa...
Metastatic Naso...
Metastatic Phar...
Metastatic Sino...
Recurrent Head ...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Nasop...
Recurrent Phary...
Recurrent Sinon...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IV Nasoph...
Stage IV Oropha...
Stage IV Sinona...
Atezolizumab
Bevacizumab
Biospecimen Col...
Carboplatin
Cetuximab
Cisplatin
Computed Tomogr...
Docetaxel
Echocardiograph...
Magnetic Resona...
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck CancerNCT02068157
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Metas...
Recurrent Oral ...
Recurrent Oroph...
Tongue Carcinom...
Laboratory Biom...
Photodynamic Th...
Porfimer Sodium
18 Years - Roswell Park Cancer Institute
Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck CancerNCT00458978
Recurrent Hypop...
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Metas...
Recurrent Nasal...
Recurrent Nasop...
Recurrent Oral ...
Recurrent Oroph...
Recurrent Saliv...
Salivary Gland ...
Squamous Cell C...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Laryng...
Stage IV Lip an...
Stage IV Major ...
Stage IV Nasal ...
Stage IV Nasoph...
Stage IV Oral C...
Stage IV Oropha...
Tongue Carcinom...
Untreated Metas...
Cediranib Malea...
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing SurgeryNCT02007200
Recurrent Hypop...
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Oral ...
Recurrent Oroph...
Stage I Hypopha...
Stage I Larynge...
Stage I Larynge...
Stage I Lip and...
Stage I Oral Ca...
Stage I Orophar...
Stage II Hypoph...
Stage II Laryng...
Stage II Laryng...
Stage II Lip an...
Stage II Oral C...
Stage II Oropha...
Stage III Hypop...
Stage III Laryn...
Stage III Laryn...
Stage III Lip a...
Stage III Oral ...
Stage III Oroph...
Stage IV Hypoph...
Stage IVA Laryn...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oral ...
Stage IVA Oroph...
Tongue Carcinom...
Laboratory Biom...
Soy Isoflavones
Survey Administ...
19 Years - 79 YearsNational Cancer Institute (NCI)
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck CancerNCT01254617
Recurrent Colon...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Metas...
Recurrent Nasal...
Recurrent Nasop...
Recurrent Oral ...
Recurrent Oroph...
Recurrent Recta...
Recurrent Saliv...
Salivary Gland ...
Squamous Cell C...
Stage IV Hypoph...
Stage IV Nasoph...
Stage IVA Colon...
Stage IVA Laryn...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Major...
Stage IVA Nasal...
Stage IVA Oral ...
Stage IVA Oroph...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Laryn...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Major...
Stage IVB Nasal...
Stage IVB Oral ...
Stage IVB Oroph...
Stage IVB Recta...
Stage IVC Laryn...
Stage IVC Laryn...
Stage IVC Lip a...
Stage IVC Major...
Stage IVC Nasal...
Stage IVC Oral ...
Stage IVC Oroph...
Tongue Carcinom...
Cetuximab
Laboratory Biom...
Lenalidomide
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: